JHL Biotech receives China approval for cancer Biosimilar

Biologics |  News | 0 Comment | 16 Oct, 2018

JHL Biotech announced that the National Medical Products Administration of the PRC (NMPA) has approved JHL's Phase I and Phase III Clinical Trial Application for a proposed ...Read more

Singapore researchers discover new treatment for malaria

Biologics |  News | 0 Comment | 08 Oct, 2018

A team of scientists from Massachusetts Institute of Technology (MIT), Singapore-MIT Alliance for Research and Technology (SMART) and Nanyang Technological University, S...Read more

Researchers develop rapid test for infectious diseases

Biologics |  News | 0 Comment | 04 Oct, 2018

Researchers from Eindhoven University of Technology (The Netherlands) and Keio University (Japan) have developed a practicable and reliable way to test for infectious diseases. The test sh...Read more

RMIT, Atmo sign licence agreement for gut sensors

Biologics |  News | 1 Comment | 03 Oct, 2018

RMIT University in Australia has signed a commercial licence agreement with start-up Atmo Biosciences for ingestible sensors developed to measure gases in the gut in order to diagnose gut-r...Read more

FDA OKs prefilled syringe formulations for Roche's Xolair

Biologics |  News | 0 Comment | 01 Oct, 2018

Singapore - Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) has approved 75 mg/0.5 mL and 150 mg/1 mL single-dose prefilled syringes (PFS)...Read more

Breakthrough research by scientists on Chikungunya virus

Biologics |  News | 0 Comment | 27 Sep, 2018

Singapore – Researchers from A*STAR’s Singapore Immunology Network (SIgN) have discovered that the Plasmodium parasite responsible for Malaria triggers certain immune pathways t...Read more

Breakthrough treatment helps prolong life of metastatic lung cancer patients

Biologics |  News | 0 Comment | 26 Sep, 2018

Singapore - When lung cancer has spread, or metastasized, to other parts of the body, standard chemotherapy offers only a modest survival benefit.  Now, in a major advance describ...Read more

NUS scientists reconstruct healthy liver cells

Biologics |  News | 0 Comment | 24 Sep, 2018

A team of pharmaceutical scientists at the National University of Singapore (NUS), together with clinicians from the National University Health System (NUHS), have developed a nanomaterial-...Read more

Mylan, Fujifilm receive European marketing authorization for Hulio Biosimilar

Biologics |  News | 0 Comment | 24 Sep, 2018

Mylan  and Fujifilm Kyowa Kirin Biologics recently announced that the European Commission (EC) has granted marketing authorization for Hulio (Product Code: FKB327), a biosimilar t...Read more

Chinese scientists design new photoacoustic imaging technology

Biologics |  News | 0 Comment | 21 Sep, 2018

Researchers from Jinan University in China have developed a smart photoacoustic imaging approach by using a combination of laser light and ultrasound. The new technique is believed to have ...Read more

Celltrion signs agreement for atherosclerosis drugs development

Biologics |  News | 0 Comment | 20 Sep, 2018

Celltrion, a leading biopharmaceutical company headquartered in Incheon, Korea has signed an ‘Incubation’ agreement with Emory University in Atlanta to support the research and ...Read more

NUS team invents new diagnostic device

Biologics |  News | 0 Comment | 19 Sep, 2018

A multidisciplinary team of researchers at the National University of Singapore (NUS) has developed a portable, easy-to-use device for quick and accurate screening of diseases. This versati...Read more

Canadian researchers to convert any blood group to Type O

Biologics |  News | 0 Comment | 18 Sep, 2018

A team of researchers from the University of British Columbia, Canada has isolated an enzyme in the gut that reliably converts any type of blood into type O, which is compatible with nearly...Read more

EpimAb announces IND filing for EMB01

Biologics |  News | 0 Comment | 16 Sep, 2018

EpimAb Biotherapeutics, an emerging Shanghai-based biopharmaceutical company specializing in bispecific antibodies, has announced that it has filed an IND for its most advanced therapeutic ...Read more

Manchester team develops non-antibiotic drug against TB

Biologics |  News | 0 Comment | 12 Sep, 2018

A group of scientists at the University of Manchester, UK has developed the first non-antibiotic drug to successfully treat tuberculosis in animals. The team hopes that the compound develo...Read more

UK regulator declines Roche MS drug

Biologics |  News | 0 Comment | 10 Sep, 2018

Singapore - The UK's National Institute for Health and Care Excellence rejected Roche's OCREVUS (ocrelizumab) for provision to adults with primary progressive multiple sclerosis. The ...Read more

BI partners with Tsinghua for immuno therapies

Biologics |  News | 0 Comment | 05 Sep, 2018

Boehringer Ingelheim (BI) and Tsinghua University in Beijing have announced a collaboration aiming to research and develop immunological therapies for infectious diseases. Scientists will w...Read more

Ground-breaking approach accelerates drug discovery process

Biologics |  News | 0 Comment | 04 Sep, 2018

Singapore - An international collaboration between Imperial College London, Singapore’s Duke-NUS Medical School and Belgium-based pharmaceutical company UCB led to the discovery of a ...Read more